Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR)

International Journal of Cancer

Volumn 102, Issue 1, 2002, Pages 7-14

  Xia, Yuhe ^a   Wong, Nai Sum ^b   Fong, Wang Fun ^c   Tideman, Henk ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

4 Hydroxyphenyl)retinamide; Apoptosis; Cell cycle; Gadd153

Indexed keywords

FENRETINIDE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MESSENGER RNA; PROTEIN; RETINOIC ACID;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEINS; CELL CYCLE; CELL DIVISION; DNA PRIMERS; FENRETINIDE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LUCIFERASES; MICROSCOPY, FLUORESCENCE; NEOPLASMS, GLANDULAR AND EPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMIDS; POLYMERASE CHAIN REACTION; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0036837429     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10664     Document Type: Article

References (29)

1. Favoni RE, de Cupis A, Bruno S, Yee D, Ferrera A, Pirani P, Costa A, Decensi A. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines. Br J Cancer 1998;77:2138-47.
2. Sun SY, Yue P, Lotan R. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells. Mol Pharmacol 1999; 55:403-10.
3. DiPietrantonio AM, Hsieh TC, OIson SC, Wu JM. Regulation of GI/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR). Int J Cancer 1998;78:53-61.
4. Scher RL, Saito W, Dodge RK, Richtsmeier WJ, Fine RL. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines. Otolaryngol Head Neck Surg 1998; 118:464- 71.
5. Veronesi U, De Palo G, Marubini E, Costa A, Formelli F, Mariani L, Decensi A. Camerini, T, Del Turco MR, Di Mauro MG, Muraca MG, Del Vecchio M, et al. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst 1999;91:1847-56.
6. Liu G, Wu M, Levi G, Ferrari N. Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression. Int J Cancer 1998;78:248-54.
7. Sabichi AL. Hendricks DT, Bober MA, Birrer MJ. Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide. J Natl Cancer Inst 1998;90:597-605.
8. Oridate N, Lotan D, Xu XC, Hong WK, Lotan R. Differential induction of apoptosis by all-transretinoic acid and N-(4-hydroxyphenyl)-retinamide in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 1996;2:855-63.
9. Sheikh MS, Shao ZM, Li XS, Ordonez JV, Conley BA, Wu S, Dawson MI, Han QX, Chao WR, Quick T. N-(4-hydroxyphenyl)reti namide (4-HPR)- mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis 1995;16:2477-86.
10. Suzuki S, Higuchi M, Proske RJ, Oridate N, Hong WK, Lotan R. Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4- hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. Oncogene 1999;: 18:6380-7.
11. Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, Reynolds CP. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines. J Natl Cancer Inst 1999;91: 1138-46.
12. Hail N Jr, Lotan R. Mitochondrial respiration is uniquely associated with the prooxidant and apoptotic effects of N-(4-hydroxyphenyl)retinamide. J Biol Chem 2001;276:45614-21.
13. Sizhong Z, Xiukung G, Yi Z. Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma. Int J Cancer 1983;31:587-90.
14. Fornace AJ, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 1989;9:4196-203.
15. Carlson SG, Fawcett TW, Bartlett JD, Bernier M, Holbrook NJ. Regulation of the C/EBP-related gene gadd153 by glucose deprivation. Mol Cell Biol 1993;13:4736-44.
16. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
17. Lan L, Wong NS, Phosphatidylinositol 3-kinase and protein kinase C are required for the inhibition of caspase activity by epidermal growth factor. FEBS Lett 1999;444:90-6.
18. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955-9.
19. Park JS, Luethy JD, Wang MG, Fargnoli J, Fornace AJ, McBride OW, Holbrook NJ. Isolation, characterization and chromosomal localization of the human GADD153 gene. Gene 1992; 116:259 -67.
20. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H. Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-12.
21. Fawcett TW, Eastman HB, Martindale JL, Holbrook NJ. Physical and functional association between GADD153 and CCAAT/enhancer-binding protein beta during cellular stress. J Biol Chem 1996;271: 14285-9.
22. Bruhat A, Jousse C, Carraro V, Reimold AM, Ferrara M, Fafoumoux P. Amino acids control mammalian gene transcription: activating transcription factor 2 is essential for the amino acid responsiveness of the CHOP promoter. Mol Cell Biol 2000;20:7192-204.
23. Sok J, Wang XZ, Batchvarova N, Kuroda M, Harding H, Ron D. CHOP-dependent stress -inducible expression of a novel form of carbonic anhydrase VI. Mol Cell Biol 1999;19:495-504.
24. Guyton KZ, Xu Q, Holbrook NJ. Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP- 1 element. Biochem J 1996;314:547-54.
25. Fanjul AN, Delia D, Pierotti MA, Rideout D, Yu JQ, Pfahl M, Qiu J. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J Biol Chem 1996;271:22441-6.
26. Pergolizzi R, Appierto V, Crosti M, Cavadini E, Cleris L, Guffanti A, Formelli F. Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells. Int J Cancer 1999;81:829-34.
27. Piedrafita FJ, Pfahl M. Nuclear retinoid receptors and mechanisms of action. In: Nau H, Blaner WS, eds. Retinoids: the biochemical and molecular basis of Vitamin A and retinoid action. Berlin: Springer, 1999.153-84.
28. Shimada J, Suzuki Y, Kim SJ, Wang PC, Matsumura M, Kojima S. Transactivation via RAR/RXR -Spl interaction: characterization of binding between Spl SpI and GC box motif. Mol Endocrinol 2001;15:1677-92.
29. Barone MV, Crozat A, Tabaee A, Philipson L, Ron D. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of GI/S arrest. Genes Dev 1994;8:453-64.